Immunotherapy for leukemia may affect the bone marrow environment, cancer researchers find
Peer-Reviewed Publication
Updates every hour. Last Updated: 4-Aug-2025 19:11 ET (4-Aug-2025 23:11 GMT/UTC)
Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of treatment — immunotherapy — may help change the environment where cancer cells live, possibly helping the immune system respond more effectively.
Regular walking is widely recognized for its significant benefits to overall health and well-being. Previous research has primarily focused on middle-to-high-income White populations. Now, a novel analysis using data from the Southern Community Cohort Study, involving 79,856 predominantly low-income and Black individuals across 12 southeastern US states, confirms the benefits of regular walking, especially at a faster pace, within a crucial, underrepresented group. The new study appearing in the American Journal of Preventive Medicine, published by Elsevier, underscores the importance of promoting walking, particularly at a brisk pace, as an effective form of physical activity for improving health.
Lupus is a “classic” autoimmune disease.
It causes the immune system’s first-line viral defenses — known as interferons — to attack the body. Nearly every organ is at risk, leading to conditions like kidney and heart disease.
But unlike many other autoimmune or chronic illnesses, lupus can improve as patients reach their 60s and 70s.
In a new analysis of the RECOVER-Adult cohort, Mass General Brigham researchers found a two- to three-times higher risk of long COVID in those with social risk factors, including financial hardship, food insecurity, experiences of medical discrimination, and skipped medical care due to cost. Findings are published in Annals of Internal Medicine.